Factors affecting prescription of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus with established cardiovascular disease/ chronic kidney disease in Hong Kong: a qualitative study | BMC Primary Care | Full Text

https://bmcprimcare.biomedcentral.com/articles/10.1186/s12875-022-01928-z